Search Results - "Perou CM"

This result is not displayed to guests.
Login for full access.

DNA microarrays in breast cancer: the promise of personalised medicine.

Authors: Ramaswamy S Perou CM

Source: Lancet. 5/10/2003, Vol. 361 Issue 9369, p1576-1577. 2p.

Concordance among gene-expression-based predictors for breast cancer.

Authors: Fan C Oh DS Wessels L et al.

Source: New England Journal of Medicine. 8/10/2006, Vol. 355 Issue 6, p560-569. 10p.

Gene-expression-based predictors for breast cancer.

Authors: Goetz MP Ingle JN Couch FJ et al.

Source: New England Journal of Medicine. 2/15/2007, Vol. 356 Issue 7, p752-753. 2p.

URL: 24929136

Anti-CSF-1R therapy with combined immuno-chemotherapy coordinate an adaptive immune response to eliminate macrophage enriched triple negative breast cancers.

Authors: Pedroza DA Yuan X Liu F et al.

Source: Nature communications [Nat Commun] 2026 Jan 03; Vol. 17 (1), pp. 1193. Date of Electronic Publication: 2026 Jan 03.

Publication Type: Journal Article

Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

HER2DX in older patients with HER2-positive early breast cancer: extended follow-up from the RESPECT trial of trastuzumab ± chemotherapy.

Authors: Nozawa K Sawaki M Uemura Y et al.

Source: Nature communications [Nat Commun] 2025 Nov 04; Vol. 16 (1), pp. 9585. Date of Electronic Publication: 2025 Nov 04.

Publication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial

Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

Prognostic significance of CD8+ T cell Spatial Biomarkers in ER+ and ER- breast cancer: A retrospective cohort study.

Authors: Walker AE Gao X Wang Q et al.

Source: PLoS medicine [PLoS Med] 2025 Oct 15; Vol. 22 (10), pp. e1004647. Date of Electronic Publication: 2025 Oct 15 (Print Publication: 2025).

Publication Type: Journal Article

Journal Info: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101231360 Publication Model: eCollection Cited Medium: Internet ISSN: 1549-1676 (Electronic) Linking ISSN: 15491277 NLM ISO Abbreviation: PLoS Med Subsets: MEDLINE

Single-cell transcriptomics reveals immune landscape dynamics in metastatic hormone receptor-positive breast cancer treated with abemaciclib and endocrine therapy.

Authors: Strawser CH Chakraborty B Michaud D et al.

Source: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2026 May 13. Date of Electronic Publication: 2026 May 13.

Publication Type: Journal Article

Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

Exogenous Hormones, Tumor Intrinsic Subtypes, and Breast Cancer.

Authors: Le Cornet C Jung AY Behrens S et al.

Source: JAMA network open [JAMA Netw Open] 2025 Jul 01; Vol. 8 (7), pp. e2519236. Date of Electronic Publication: 2025 Jul 01.

Publication Type: Journal Article; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't

Journal Info: Publisher: American Medical Association Country of Publication: United States NLM ID: 101729235 Publication Model: Electronic Cited Medium: Internet ISSN: 2574-3805 (Electronic) Linking ISSN: 25743805 NLM ISO Abbreviation: JAMA Netw Open Subsets: MEDLINE

HER2DX ERBB2 mRNA score in first-line advanced HER2-positive breast cancer treated with chemotherapy, trastuzumab, and pertuzumab.

Authors: Sánchez-Bayona R Martínez-Sáez O Romero-Romero D et al.

Source: NPJ breast cancer [NPJ Breast Cancer] 2025 Apr 25; Vol. 11 (1), pp. 37. Date of Electronic Publication: 2025 Apr 25.

Publication Type: Journal Article

Journal Info: Publisher: Breast Cancer Research Foundation Country of Publication: United States NLM ID: 101674891 Publication Model: Electronic Cited Medium: Print ISSN: 2374-4677 (Print) Linking ISSN: 23744677 NLM ISO Abbreviation: NPJ Breast Cancer Subsets: PubMed not MEDLINE

Integrated Multi-omic Profiling Identifies BRD8/EP400 as a Pivotal Chromatin Module Mediating Anti-HER2 Response in HR+/HER2+ Breast Cancer.

Authors: Gao A Khatri PH Ma G et al.

Source: Cancer research [Cancer Res] 2026 Mar 26. Date of Electronic Publication: 2026 Mar 26.

Publication Type: Journal Article

Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 2984705R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1538-7445 (Electronic) Linking ISSN: 00085472 NLM ISO Abbreviation: Cancer Res Subsets: MEDLINE

Transcriptomic profiling of mouse mammary tumors enables prognostic and predictive biomarker discovery for human breast cancers.

Authors: Sutcliffe MD Mott KR Yilmaz-Swenson T et al.

Source: BioRxiv : the preprint server for biology [bioRxiv] 2026 Mar 03. Date of Electronic Publication: 2026 Mar 03.

Publication Type: Journal Article; Preprint

Journal Info: Country of Publication: United States NLM ID: 101680187 Publication Model: Electronic Cited Medium: Internet ISSN: 2692-8205 (Electronic) Linking ISSN: 26928205 NLM ISO Abbreviation: bioRxiv Subsets: PubMed not MEDLINE

Talimogene laherparepvec and atezolizumab in HER2-negative breast cancer following neoadjuvant chemotherapy: a window-of-opportunity phase II trial (SOLTI-1503 PROMETEO).

Authors: Pascual T Vidal M Cejalvo JM et al.

Source: Nature communications [Nat Commun] 2026 Feb 16; Vol. 17 (1). Date of Electronic Publication: 2026 Feb 16.

Publication Type: Journal Article; Clinical Trial, Phase II

Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

MERTK inhibition cooperates with immunomodulatory cyclophosphamide to induce CXCL9⁺ monocyte-macrophage programming and durable anti-tumor immunity in triple negative breast cancer.

Authors: Smith AJ Schrank Z Guan N et al.

Source: BioRxiv : the preprint server for biology [bioRxiv] 2026 Feb 06. Date of Electronic Publication: 2026 Feb 06.

Publication Type: Journal Article; Preprint

Journal Info: Country of Publication: United States NLM ID: 101680187 Publication Model: Electronic Cited Medium: Internet ISSN: 2692-8205 (Electronic) Linking ISSN: 26928205 NLM ISO Abbreviation: bioRxiv Subsets: PubMed not MEDLINE

Identifying Locally Recurrent Versus Second Primary Breast Cancer: Genomic Versus Clinical Criteria from Carolina Breast Cancer Study Phase III.

Authors: Van Alsten SC Love MI Calhoun BC et al.

Source: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology [Cancer Epidemiol Biomarkers Prev] 2026 Feb 03; Vol. 35 (2), pp. 311-320.

Publication Type: Journal Article; Clinical Trial, Phase III

Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9200608 Publication Model: Print Cited Medium: Internet ISSN: 1538-7755 (Electronic) Linking ISSN: 10559965 NLM ISO Abbreviation: Cancer Epidemiol Biomarkers Prev Subsets: MEDLINE

Proteotranscriptomic Dissection of Breast Cancer T Cell States Identifies CD103+ Tfh-derived Cytotoxic Cells Linked to Immunotherapy Response.

Authors: Al-Eryani G Van Der Leij S Masle-Farquhar E et al.

Source: Research square [Res Sq] 2026 Jan 07. Date of Electronic Publication: 2026 Jan 07.

Publication Type: Journal Article; Preprint

Journal Info: Country of Publication: United States NLM ID: 101768035 Publication Model: Electronic Cited Medium: Internet ISSN: 2693-5015 (Electronic) Linking ISSN: 26935015 NLM ISO Abbreviation: Res Sq Subsets: PubMed not MEDLINE

Crafted experiments to evaluate feature selection methods for single-cell RNA-seq data.

Authors: Liu S Corcoran DL Garcia-Recio S et al.

Source: NAR genomics and bioinformatics [NAR Genom Bioinform] 2025 Mar 19; Vol. 7 (1), pp. lqaf023. Date of Electronic Publication: 2025 Mar 19 (Print Publication: 2025).

Publication Type: Journal Article

Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 101756213 Publication Model: eCollection Cited Medium: Internet ISSN: 2631-9268 (Electronic) Linking ISSN: 26319268 NLM ISO Abbreviation: NAR Genom Bioinform Subsets: MEDLINE

Prognostic and molecular multi-platform analysis of CALGB 40603 (Alliance) and public triple-negative breast cancer datasets.

Authors: Felsheim BM Fernandez-Martinez A Fan C et al.

Source: NPJ breast cancer [NPJ Breast Cancer] 2025 Mar 08; Vol. 11 (1), pp. 24. Date of Electronic Publication: 2025 Mar 08.

Publication Type: Journal Article

Journal Info: Publisher: Breast Cancer Research Foundation Country of Publication: United States NLM ID: 101674891 Publication Model: Electronic Cited Medium: Print ISSN: 2374-4677 (Print) Linking ISSN: 23744677 NLM ISO Abbreviation: NPJ Breast Cancer Subsets: PubMed not MEDLINE

Phase II study of MEK inhibitor trametinib alone and in combination with AKT inhibitor GSK2141795/uprosertib in patients with metastatic triple negative breast cancer.

Authors: Prasath V Boutrid H Wesolowski R et al.

Source: Breast cancer research and treatment [Breast Cancer Res Treat] 2025 Feb; Vol. 210 (1), pp. 179-189. Date of Electronic Publication: 2024 Dec 07.

Publication Type: Journal Article; Clinical Trial, Phase II; Multicenter Study

Journal Info: Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE

Understanding metastasis mixed-treatment responses through genomic analyses.

Authors: Garcia-Recio S Zagami P Felsheim BM et al.

Source: NPJ breast cancer [NPJ Breast Cancer] 2025 Jan 30; Vol. 11 (1), pp. 9. Date of Electronic Publication: 2025 Jan 30.

Publication Type: Journal Article

Journal Info: Publisher: Breast Cancer Research Foundation Country of Publication: United States NLM ID: 101674891 Publication Model: Electronic Cited Medium: Print ISSN: 2374-4677 (Print) Linking ISSN: 23744677 NLM ISO Abbreviation: NPJ Breast Cancer Subsets: PubMed not MEDLINE